1. Home
  2. WFCF vs INKT Comparison

WFCF vs INKT Comparison

Compare WFCF & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$13.24

Market Cap

61.3M

Sector

Technology

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$14.21

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
INKT
Founded
1996
2017
Country
United States
United States
Employees
N/A
15
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.3M
70.6M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
WFCF
INKT
Price
$13.24
$14.21
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
3.8K
52.7K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$20,774,416.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.60
N/A
Revenue Growth
16.69
N/A
52 Week Low
$9.69
$6.66
52 Week High
$13.75
$76.00

Technical Indicators

Market Signals
Indicator
WFCF
INKT
Relative Strength Index (RSI) 55.21 68.03
Support Level $11.79 $13.43
Resistance Level $13.63 $15.99
Average True Range (ATR) 0.45 1.13
MACD -0.05 0.41
Stochastic Oscillator 61.50 84.32

Price Performance

Historical Comparison
WFCF
INKT

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: